Global Synthetic Opioids Market Growth 2020-2025

Publication Month: Nov 2020 | No. of Pages: 139 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the Synthetic Opioids market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Synthetic Opioids business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Opioids market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Synthetic Opioids, covering the supply chain analysis, impact assessment to the Synthetic Opioids market size growth rate in several scenarios, and the measures to be undertaken by Synthetic Opioids companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Methadone
Fentanyl
Meperidine
Hydrocodone
Oxymorphone
Oxycodone

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Management
De-addiction

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Purdue Pharma
Indivior
Pfizer
Teva Pharmaceuticals
Endo International
Janssen Pharmaceuticals
Mylan
West-Ward Pharmaceuticals
Impax Laboratories
Mallinckrodt Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Synthetic Opioids consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Synthetic Opioids market by identifying its various subsegments.
Focuses on the key global Synthetic Opioids manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Synthetic Opioids with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Synthetic Opioids submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Synthetic Opioids Consumption 2015-2025
2.1.2 Synthetic Opioids Consumption CAGR by Region
2.2 Synthetic Opioids Segment by Type
2.2.1 Methadone
2.2.2 Fentanyl
2.2.3 Meperidine
2.2.4 Hydrocodone
2.2.5 Oxymorphone
2.2.6 Oxycodone
2.3 Synthetic Opioids Consumption by Type
2.3.1 Global Synthetic Opioids Consumption Market Share by Type (2015-2020)
2.3.2 Global Synthetic Opioids Revenue and Market Share by Type (2015-2020)
2.3.3 Global Synthetic Opioids Sale Price by Type (2015-2020)
2.4 Synthetic Opioids Segment by Application
2.4.1 Pain Management
2.4.2 De-addiction
2.5 Synthetic Opioids Consumption by Application
2.5.1 Global Synthetic Opioids Consumption Market Share by Type (2015-2020)
2.5.2 Global Synthetic Opioids Value and Market Share by Type (2015-2020)
2.5.3 Global Synthetic Opioids Sale Price by Type (2015-2020)

3 Global Synthetic Opioids by Company
3.1 Global Synthetic Opioids Sales Market Share by Company
3.1.1 Global Synthetic Opioids Sales by Company (2018-2020)
3.1.2 Global Synthetic Opioids Sales Market Share by Company (2018-2020)
3.2 Global Synthetic Opioids Revenue Market Share by Company
3.2.1 Global Synthetic Opioids Revenue by Company (2018-2020)
3.2.2 Global Synthetic Opioids Revenue Market Share by Company (2018-2020)
3.3 Global Synthetic Opioids Sale Price by Company
3.4 Global Synthetic Opioids Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Synthetic Opioids Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Synthetic Opioids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Synthetic Opioids by Regions
4.1 Synthetic Opioids by Regions
4.2 Americas Synthetic Opioids Consumption Growth
4.3 APAC Synthetic Opioids Consumption Growth
4.4 Europe Synthetic Opioids Consumption Growth
4.5 Middle East & Africa Synthetic Opioids Consumption Growth

5 Americas
5.1 Americas Synthetic Opioids Consumption by Countries
5.1.1 Americas Synthetic Opioids Consumption by Countries (2015-2020)
5.1.2 Americas Synthetic Opioids Value by Countries (2015-2020)
5.2 Americas Synthetic Opioids Consumption by Type
5.3 Americas Synthetic Opioids Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Synthetic Opioids Consumption by Regions
6.1.1 APAC Synthetic Opioids Consumption by Regions (2015-2020)
6.1.2 APAC Synthetic Opioids Value by Regions (2015-2020)
6.2 APAC Synthetic Opioids Consumption by Type
6.3 APAC Synthetic Opioids Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Synthetic Opioids by Countries
7.1.1 Europe Synthetic Opioids Consumption by Countries (2015-2020)
7.1.2 Europe Synthetic Opioids Value by Countries (2015-2020)
7.2 Europe Synthetic Opioids Consumption by Type
7.3 Europe Synthetic Opioids Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Synthetic Opioids by Countries
8.1.1 Middle East & Africa Synthetic Opioids Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Synthetic Opioids Value by Countries (2015-2020)
8.2 Middle East & Africa Synthetic Opioids Consumption by Type
8.3 Middle East & Africa Synthetic Opioids Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Synthetic Opioids Distributors
10.3 Synthetic Opioids Customer

11 Global Synthetic Opioids Market Forecast
11.1 Global Synthetic Opioids Consumption Forecast (2021-2025)
11.2 Global Synthetic Opioids Forecast by Regions
11.2.1 Global Synthetic Opioids Forecast by Regions (2021-2025)
11.2.2 Global Synthetic Opioids Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Synthetic Opioids Forecast by Type
11.8 Global Synthetic Opioids Forecast by Application

12 Key Players Analysis
12.1 Purdue Pharma
12.1.1 Company Information
12.1.2 Synthetic Opioids Product Offered
12.1.3 Purdue Pharma Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Purdue Pharma Latest Developments
12.2 Indivior
12.2.1 Company Information
12.2.2 Synthetic Opioids Product Offered
12.2.3 Indivior Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Indivior Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Synthetic Opioids Product Offered
12.3.3 Pfizer Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Teva Pharmaceuticals
12.4.1 Company Information
12.4.2 Synthetic Opioids Product Offered
12.4.3 Teva Pharmaceuticals Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Teva Pharmaceuticals Latest Developments
12.5 Endo International
12.5.1 Company Information
12.5.2 Synthetic Opioids Product Offered
12.5.3 Endo International Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Endo International Latest Developments
12.6 Janssen Pharmaceuticals
12.6.1 Company Information
12.6.2 Synthetic Opioids Product Offered
12.6.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Janssen Pharmaceuticals Latest Developments
12.7 Mylan
12.7.1 Company Information
12.7.2 Synthetic Opioids Product Offered
12.7.3 Mylan Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Mylan Latest Developments
12.8 West-Ward Pharmaceuticals
12.8.1 Company Information
12.8.2 Synthetic Opioids Product Offered
12.8.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 West-Ward Pharmaceuticals Latest Developments
12.9 Impax Laboratories
12.9.1 Company Information
12.9.2 Synthetic Opioids Product Offered
12.9.3 Impax Laboratories Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Impax Laboratories Latest Developments
12.10 Mallinckrodt Pharmaceuticals
12.10.1 Company Information
12.10.2 Synthetic Opioids Product Offered
12.10.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Mallinckrodt Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Synthetic Opioids Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Methadone
Table 5. Major Players of Fentanyl
Table 6. Major Players of Meperidine
Table 7. Major Players of Hydrocodone
Table 8. Major Players of Oxymorphone
Table 9. Major Players of Oxycodone
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Synthetic Opioids Consumption Market Share by Type (2015-2020)
Table 12. Global Synthetic Opioids Revenue by Type (2015-2020) ($ million)
Table 13. Global Synthetic Opioids Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Synthetic Opioids Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Synthetic Opioids Consumption Market Share by Application (2015-2020)
Table 17. Global Synthetic Opioids Value by Application (2015-2020)
Table 18. Global Synthetic Opioids Value Market Share by Application (2015-2020)
Table 19. Global Synthetic Opioids Sale Price by Application (2015-2020)
Table 20. Global Synthetic Opioids Sales by Company (2017-2019) (K Pcs)
Table 21. Global Synthetic Opioids Sales Market Share by Company (2017-2019)
Table 22. Global Synthetic Opioids Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Synthetic Opioids Revenue Market Share by Company (2017-2019)
Table 24. Global Synthetic Opioids Sale Price by Company (2017-2019)
Table 25. Global Synthetic Opioids Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Synthetic Opioids Products Offered
Table 27. Synthetic Opioids Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Synthetic Opioids Consumption by Regions 2015-2020 (K Pcs)
Table 29. Global Synthetic Opioids Consumption Market Share by Regions 2015-2020
Table 30. Global Synthetic Opioids Value by Regions 2015-2020 ($ Millions)
Table 31. Global Synthetic Opioids Value Market Share by Regions 2015-2020
Table 32. Americas Synthetic Opioids Consumption by Countries (2015-2020) (K Pcs)
Table 33. Americas Synthetic Opioids Consumption Market Share by Countries (2015-2020)
Table 34. Americas Synthetic Opioids Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Synthetic Opioids Value Market Share by Countries (2015-2020)
Table 36. Americas Synthetic Opioids Consumption by Type (2015-2020) (K Pcs)
Table 37. Americas Synthetic Opioids Consumption Market Share by Type (2015-2020)
Table 38. Americas Synthetic Opioids Consumption by Application (2015-2020) (K Pcs)
Table 39. Americas Synthetic Opioids Consumption Market Share by Application (2015-2020)
Table 40. APAC Synthetic Opioids Consumption by Countries (2015-2020) (K Pcs)
Table 41. APAC Synthetic Opioids Consumption Market Share by Countries (2015-2020)
Table 42. APAC Synthetic Opioids Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Synthetic Opioids Value Market Share by Regions (2015-2020)
Table 44. APAC Synthetic Opioids Consumption by Type (2015-2020) (K Pcs)
Table 45. APAC Synthetic Opioids Consumption Market Share by Type (2015-2020)
Table 46. APAC Synthetic Opioids Consumption by Application (2015-2020) (K Pcs)
Table 47. APAC Synthetic Opioids Consumption Market Share by Application (2015-2020)
Table 48. Europe Synthetic Opioids Consumption by Countries (2015-2020) (K Pcs)
Table 49. Europe Synthetic Opioids Consumption Market Share by Countries (2015-2020)
Table 50. Europe Synthetic Opioids Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Synthetic Opioids Value Market Share by Countries (2015-2020)
Table 52. Europe Synthetic Opioids Consumption by Type (2015-2020) (K Pcs)
Table 53. Europe Synthetic Opioids Consumption Market Share by Type (2015-2020)
Table 54. Europe Synthetic Opioids Consumption by Application (2015-2020) (K Pcs)
Table 55. Europe Synthetic Opioids Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Synthetic Opioids Consumption by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Synthetic Opioids Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Synthetic Opioids Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Synthetic Opioids Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Synthetic Opioids Consumption by Type (2015-2020) (K Pcs)
Table 61. Middle East & Africa Synthetic Opioids Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Synthetic Opioids Consumption by Application (2015-2020) (K Pcs)
Table 63. Middle East & Africa Synthetic Opioids Consumption Market Share by Application (2015-2020)
Table 64. Synthetic Opioids Distributors List
Table 65. Synthetic Opioids Customer List
Table 66. Global Synthetic Opioids Consumption Forecast by Countries (2021-2025) (K Pcs)
Table 67. Global Synthetic Opioids Consumption Market Forecast by Regions
Table 68. Global Synthetic Opioids Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Synthetic Opioids Value Market Share Forecast by Regions
Table 70. Global Synthetic Opioids Consumption Forecast by Type (2021-2025) (K Pcs)
Table 71. Global Synthetic Opioids Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Synthetic Opioids Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Synthetic Opioids Value Market Share Forecast by Type (2021-2025)
Table 74. Global Synthetic Opioids Consumption Forecast by Application (2021-2025) (K Pcs)
Table 75. Global Synthetic Opioids Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Synthetic Opioids Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Synthetic Opioids Value Market Share Forecast by Application (2021-2025)
Table 78. Purdue Pharma Product Offered
Table 79. Purdue Pharma Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 80. Purdue Pharma Main Business
Table 81. Purdue Pharma Latest Developments
Table 82. Purdue Pharma Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 83. Indivior Product Offered
Table 84. Indivior Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 85. Indivior Main Business
Table 86. Indivior Latest Developments
Table 87. Indivior Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Product Offered
Table 89. Pfizer Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Pfizer Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Pharmaceuticals Product Offered
Table 94. Teva Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 95. Teva Pharmaceuticals Main Business
Table 96. Teva Pharmaceuticals Latest Developments
Table 97. Teva Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo International Product Offered
Table 99. Endo International Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 100. Endo International Main Business
Table 101. Endo International Latest Developments
Table 102. Endo International Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 103. Janssen Pharmaceuticals Product Offered
Table 104. Janssen Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 105. Janssen Pharmaceuticals Main Business
Table 106. Janssen Pharmaceuticals Latest Developments
Table 107. Janssen Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Product Offered
Table 109. Mylan Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. Mylan Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 113. West-Ward Pharmaceuticals Product Offered
Table 114. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 115. West-Ward Pharmaceuticals Main Business
Table 116. West-Ward Pharmaceuticals Latest Developments
Table 117. West-Ward Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 118. Impax Laboratories Product Offered
Table 119. Impax Laboratories Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 120. Impax Laboratories Main Business
Table 121. Impax Laboratories Latest Developments
Table 122. Impax Laboratories Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
Table 123. Mallinckrodt Pharmaceuticals Product Offered
Table 124. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 125. Mallinckrodt Pharmaceuticals Main Business
Table 126. Mallinckrodt Pharmaceuticals Latest Developments
Table 127. Mallinckrodt Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Synthetic Opioids Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Synthetic Opioids
Figure 2. Synthetic Opioids Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Synthetic Opioids Consumption Growth Rate 2015-2025 (K Pcs)
Figure 5. Global Synthetic Opioids Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Methadone
Figure 7. Product Picture of Fentanyl
Figure 8. Product Picture of Meperidine
Figure 9. Product Picture of Hydrocodone
Figure 10. Product Picture of Oxymorphone
Figure 11. Product Picture of Oxycodone
Figure 12. Global Synthetic Opioids Consumption Market Share by Type (2015-2020)
Figure 13. Global Synthetic Opioids Value Market Share by Type (2015-2020)
Figure 14. Synthetic Opioids Consumed in Pain Management
Figure 15. Global Synthetic Opioids Market: Pain Management (2015-2020) (K Pcs)
Figure 16. Global Synthetic Opioids Market: Pain Management (2015-2020) ($ Millions)
Figure 17. Synthetic Opioids Consumed in De-addiction
Figure 18. Global Synthetic Opioids Market: De-addiction (2015-2020) (K Pcs)
Figure 19. Global Synthetic Opioids Market: De-addiction (2015-2020) ($ Millions)
Figure 20. Global Synthetic Opioids Consumption Market Share by Application (2015-2020)
Figure 21. Global Synthetic Opioids Value Market Share by Application (2015-2020)
Figure 22. Global Synthetic Opioids Sales Market Share by Company in 2017
Figure 23. Global Synthetic Opioids Sales Market Share by Company in 2019
Figure 24. Global Synthetic Opioids Revenue Market Share by Company in 2017
Figure 25. Global Synthetic Opioids Revenue Market Share by Company in 2019
Figure 26. Global Synthetic Opioids Sale Price by Company in 2019
Figure 27. Global Synthetic Opioids Consumption Market Share by Regions 2015-2020
Figure 28. Global Synthetic Opioids Value Market Share by Regions 2015-2020
Figure 29. Americas Synthetic Opioids Consumption 2015-2020 (K Pcs)
Figure 30. Americas Synthetic Opioids Value 2015-2020 ($ Millions)
Figure 31. APAC Synthetic Opioids Consumption 2015-2020 (K Pcs)
Figure 32. APAC Synthetic Opioids Value 2015-2020 ($ Millions)
Figure 33. Europe Synthetic Opioids Consumption 2015-2020 (K Pcs)
Figure 34. Europe Synthetic Opioids Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Synthetic Opioids Consumption 2015-2020 (K Pcs)
Figure 36. Middle East & Africa Synthetic Opioids Value 2015-2020 ($ Millions)
Figure 37. Americas Synthetic Opioids Consumption Market Share by Countries in 2019
Figure 38. Americas Synthetic Opioids Value Market Share by Countries in 2019
Figure 39. Americas Synthetic Opioids Consumption Market Share by Type in 2019
Figure 40. Americas Synthetic Opioids Consumption Market Share by Application in 2019
Figure 41. United States Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 42. United States Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 44. Canada Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 46. Mexico Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Synthetic Opioids Consumption Market Share by Countries in 2019
Figure 48. APAC Synthetic Opioids Value Market Share by Regions in 2019
Figure 49. APAC Synthetic Opioids Consumption Market Share by Type in 2019
Figure 50. APAC Synthetic Opioids Consumption Market Share by Application in 2019
Figure 51. China Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 52. China Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 54. Japan Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 56. Korea Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 58. Southeast Asia Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 59. India Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 60. India Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 62. Australia Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Synthetic Opioids Consumption Market Share by Countries in 2019
Figure 64. Europe Synthetic Opioids Value Market Share by Countries in 2019
Figure 65. Europe Synthetic Opioids Consumption Market Share by Type in 2019
Figure 66. Europe Synthetic Opioids Consumption Market Share by Application in 2019
Figure 67. Germany Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 68. Germany Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 69. France Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 70. France Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 71. UK Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 72. UK Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 74. Italy Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 76. Russia Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Synthetic Opioids Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Synthetic Opioids Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Synthetic Opioids Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Synthetic Opioids Consumption Market Share by Application in 2019
Figure 81. Egypt Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 82. Egypt Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 84. South Africa Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 86. Israel Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 88. Turkey Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Synthetic Opioids Consumption Growth 2015-2020 (K Pcs)
Figure 90. GCC Countries Synthetic Opioids Value Growth 2015-2020 ($ Millions)
Figure 91. Global Synthetic Opioids Consumption Growth Rate Forecast (2021-2025) (K Pcs)
Figure 92. Global Synthetic Opioids Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 94. Americas Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 95. APAC Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 96. APAC Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 97. Europe Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 98. Europe Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 100. Middle East & Africa Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 101. United States Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 102. United States Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 103. Canada Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 104. Canada Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 105. Mexico Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 106. Mexico Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 107. Brazil Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 108. Brazil Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 109. China Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 110. China Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 111. Japan Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 112. Japan Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 113. Korea Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 114. Korea Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 116. Southeast Asia Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 117. India Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 118. India Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 119. Australia Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 120. Australia Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 121. Germany Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 122. Germany Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 123. France Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 124. France Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 125. UK Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 126. UK Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 127. Italy Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 128. Italy Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 129. Russia Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 130. Russia Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 131. Spain Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 132. Spain Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 133. Egypt Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 134. Egypt Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 135. South Africa Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 136. South Africa Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 137. Israel Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 138. Israel Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 139. Turkey Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 140. Turkey Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Synthetic Opioids Consumption 2021-2025 (K Pcs)
Figure 142. GCC Countries Synthetic Opioids Value 2021-2025 ($ Millions)
Figure 143. Purdue Pharma Synthetic Opioids Market Share (2018-2020)
Figure 144. Indivior Synthetic Opioids Market Share (2018-2020)
Figure 145. Pfizer Synthetic Opioids Market Share (2018-2020)
Figure 146. Teva Pharmaceuticals Synthetic Opioids Market Share (2018-2020)
Figure 147. Endo International Synthetic Opioids Market Share (2018-2020)
Figure 148. Janssen Pharmaceuticals Synthetic Opioids Market Share (2018-2020)
Figure 149. Mylan Synthetic Opioids Market Share (2018-2020)
Figure 150. West-Ward Pharmaceuticals Synthetic Opioids Market Share (2018-2020)
Figure 151. Impax Laboratories Synthetic Opioids Market Share (2018-2020)
Figure 152. Mallinckrodt Pharmaceuticals Synthetic Opioids Market Share (2018-2020)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets